Clinical trial
Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors
NCT04552847 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors
- Lead sponsor
- Universitaire Ziekenhuizen KU Leuven
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- October 7, 2020
- Completion date
- February 8, 2022
- Enrollment
- 85 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.